Woody Sherman
@woody-sherman.bsky.social
* Founder and Chief Innovation Officer at Psivant Therapeutics
* Past:
* Chief Computational Scientist at Roivant
* Founding CSO at Silicon Therapeutics
* Global Head, Applications Science at Schrodinger
* Education:
* PhD MIT
* BA & BS UCSB
* Past:
* Chief Computational Scientist at Roivant
* Founding CSO at Silicon Therapeutics
* Global Head, Applications Science at Schrodinger
* Education:
* PhD MIT
* BA & BS UCSB
Past, Present & Future of In Silico Drug Discovery. Hear how AI, physics, scalable software, and integrated teams can impact drug discovery.
The field is advancing fast, but still plenty of challenges ahead.
Recording: www.linkedin.com/events/72911...
#DrugDiscovery #AI #CADD #CompChem #Biotech
The field is advancing fast, but still plenty of challenges ahead.
Recording: www.linkedin.com/events/72911...
#DrugDiscovery #AI #CADD #CompChem #Biotech
March 3, 2025 at 8:34 PM
Past, Present & Future of In Silico Drug Discovery. Hear how AI, physics, scalable software, and integrated teams can impact drug discovery.
The field is advancing fast, but still plenty of challenges ahead.
Recording: www.linkedin.com/events/72911...
#DrugDiscovery #AI #CADD #CompChem #Biotech
The field is advancing fast, but still plenty of challenges ahead.
Recording: www.linkedin.com/events/72911...
#DrugDiscovery #AI #CADD #CompChem #Biotech
Exciting news -- Psivant Therapeutics has entered a strategic research collaboration with Acellera Therapeutics to advance drug discovery and optimization. Integrating quantum chemistry, machine learning, and agentic AI -- pushing the boundaries of computation. www.businesswire.com/news/home/20...
January 29, 2025 at 5:13 PM
Exciting news -- Psivant Therapeutics has entered a strategic research collaboration with Acellera Therapeutics to advance drug discovery and optimization. Integrating quantum chemistry, machine learning, and agentic AI -- pushing the boundaries of computation. www.businesswire.com/news/home/20...